Production (Stage)
GT Biopharma, Inc.
GTBP
$3.07
-$0.11-3.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -75.88% | -71.72% | -59.92% | -48.54% | -50.72% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 156.41% | 123.81% | 552.63% | -62.50% | 105.26% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -73.11% | -69.89% | -57.89% | -48.58% | -50.42% |
|
|
|||||
| Total Current Assets | -73.11% | -69.89% | -57.89% | -48.58% | -50.42% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -80.71% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -73.18% | -70.00% | -58.14% | -48.93% | -50.65% |
|
|
|||||
| Total Accounts Payable | -25.93% | -10.98% | -34.21% | -50.96% | 2.62% |
| Total Accrued Expenses | 17.55% | 50.38% | 81.71% | 44.44% | 16.16% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -74.14% |
| Total Finance Division Other Current Liabilities | -68.02% | -76.05% | -- | -- | -- |
| Total Other Current Liabilities | -68.02% | -76.05% | -- | -- | -- |
| Total Current Liabilities | -20.91% | -11.02% | -8.41% | -22.38% | 12.86% |
|
|
|||||
| Total Current Liabilities | -20.91% | -11.02% | -8.41% | -22.38% | 12.86% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -20.91% | -11.02% | -24.11% | -41.09% | -34.59% |
|
|
|||||
| Common Stock & APIC | 0.78% | 0.58% | 0.64% | 0.74% | 0.28% |
| Retained Earnings | -1.71% | -1.93% | -1.82% | -1.68% | -1.43% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -118.47% | -122.35% | -79.05% | -53.18% | -59.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -118.47% | -122.35% | -79.05% | -53.18% | -59.31% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -118.45% | -122.34% | -79.04% | -53.18% | -59.30% |
|
|
|||||